RE:RE:RE:Not CZO but Good Aeterna Zentaris Covid NewsA vaccine is great, but those who do not have access or contract COVID will be looking for a therapeutic. I'm surprised that investors have not warmed up to Y-BG as a potential treatment. I can only guess that the story has not reached enough investors.
On a positive note, today the share price is trying a second breakout out of the trading range and a NR update is due soon as it's been 103 days since the last one [credit to Oats for keeping score :-) ]
archeo753 wrote: Maybe the slow but gradual increase in CZO shareprice bodes well for Ceapro too. Also, pretty consistent buying and selling in US OTC might be a good sign. Seems like there is interest in the company even though it has an extremely low profile. Bring on the news releases!
Ciao wrote:
Perhaps that explains why AEZS has been moving up recently. Doesn't hurt to have Gilles as a common denominator between the 2 companies.
Good news for the world on a potential oral vaccine solution to fight COVID.